Aerovate Therapeutics (AVTE) Stock Chart & Stock Price History $9.50 -0.64 (-6.31%) As of 04/30/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aerovate Therapeutics Stock Price Performance 5 Day Performance+254.48%1 Month Performance+278.49%3 Month Performance+262.60%6 Month Performance+240.50%Year-To-Date Performance+258.49%1 Year Performance-54.41% Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AVTE Stock Chart for Thursday, May, 1, 2025 AVTE Chart by TradingView Aerovate Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$10.14$9.50-6.31%$10.61$9.06283,197 shs$275.36 million04/30/2025$2.68$10.14+279.07%$13.50$9.41185,426 shs$293.91 million04/29/2025$2.68$2.68-0.19%$2.77$2.631.03 million shs$77.54 million04/28/2025$2.68$2.68$2.77$2.631.03 million shs$77.68 million04/25/2025$2.72$2.68-1.47%$2.69$2.571.10 million shs$77.68 million04/24/2025$2.74$2.72-0.73%$2.78$2.624.81 million shs$78.84 million04/23/2025$2.76$2.74-0.72%$2.83$2.72503,968 shs$79.42 million04/22/2025$2.77$2.76-0.36%$2.86$2.73993,808 shs$80.00 million04/21/2025$2.75$2.77+0.73%$2.84$2.71892,833 shs$80.29 million04/18/2025$2.75$2.75$2.79$2.63176,560 shs$79.71 million Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$2.68$2.75+2.61%$2.79$2.63176,560 shs$79.71 million04/16/2025$2.69$2.68-0.37%$2.70$2.61109,468 shs$77.68 million04/15/2025$2.71$2.69-0.74%$2.76$2.64193,085 shs$77.97 million04/14/2025$2.66$2.71+1.88%$2.76$2.62254,118 shs$78.55 million04/11/2025$2.58$2.66+3.10%$2.82$2.581.04 million shs$77.10 million04/10/2025$2.49$2.58+3.61%$2.63$2.50448,591 shs$74.78 million04/09/2025$2.51$2.49-0.80%$2.58$2.47434,568 shs$72.17 million04/09/2025$2.51$2.49-0.80%$2.58$2.47434,568 shs$72.17 million04/08/2025$2.52$2.51-0.40%$2.56$2.50199,675 shs$72.75 million04/08/2025$2.52$2.51-0.40%$2.56$2.50199,675 shs$72.75 million04/07/2025$2.49$2.52+1.20%$2.57$2.49169,652 shs$73.04 million04/04/2025$2.51$2.49-0.80%$2.58$2.4594,583 shs$72.17 million04/03/2025$2.52$2.51-0.40%$2.52$2.46110,117 shs$72.75 million04/02/2025$2.51$2.52+0.40%$2.56$2.4950,500 shs$73.04 million04/01/2025$2.51$2.51$2.55$2.4953,914 shs$72.75 million03/31/2025$2.53$2.51-0.79%$2.53$2.4593,845 shs$72.75 million Related Companies COMPASS Pathways Stock Chart Alpha Teknova Stock Chart Allogene Therapeutics Stock Chart Entrada Therapeutics Stock Chart Taysha Gene Therapies Stock Chart Heron Therapeutics Stock Chart Atyr PHARMA Stock Chart Arcturus Therapeutics Stock Chart Atai Life Sciences Stock Chart Palvella Therapeutics Stock Chart Receive AVTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVTE) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aerovate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVTE Stock Free AVTE Stock Alerts